Declan Quinn

Declan Quinn, MD is a Professor and Head of the Division of Child and Adolescent Psychiatry in the Department of Psychiatry of the College of Medicine at the University of Saskatchewan in Canada. He was a founding member of CADDRA (Canadian ADHD Resource Alliance) in 2005 and is currently President of CADDRA, which has developed the Canadian ADHD Practice Guidelines and is currently in the 3rd edition. He has been involved in the development of Canadian practice guidelines for ADHD. Dr. Quinn has also been involved in research in ADHD since the late 1980s and has a particular focus on pharmacokinetic and pharmacodynamics. He has completed studies on the isomers of Methylphenidate that led to the introduction of d-Methylphenidate as a treatment for ADHD. He has been involved in key studies looking at the Pharmacokinetics including the Bioavailability of different once-a-day preparations of d-Amphetamine and Methylphenidate in ADHD. Dr. Quinn holds degrees from Trinity College & the University of Saskatchewan.